Scitovation, LLC
Cheshire, MA Part of Solutem Group, LLC
- UEI
- MS2HXSWJZJ24
- CAGE
- 7KUT5
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Other NAICS codes in SAM.gov
-
- 541511 Custom Computer Programming Services
- 541512 Computer Systems Design Services
- 541611 Administrative Management and General Management Consulting Services
- 541620 Environmental Consulting Services
- 541690 Other Scientific and Technical Consulting Services
- 541713 Research and Development in Nanotechnology
- 541990 All Other Professional, Scientific, and Technical Services
- Corporate family
-
-
Parent
GCQBTWK31MJ7
-
Parent
GCQBTWK31MJ7
- SAM.gov registration date
- Physical address
- 560 S State Rd, Cheshire, MA 01225, USA
- Website
- scitovation.com
- Founded
- 2016
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $337,915 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $337,915 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| EO 14398 - risk assessment | CDC Pittsburgh | $337,915 |
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Cyprotex US LLC | Framingham, MA | 541380 Testing Laboratories and Services |
| Lebrun Labs LLC | Anaheim, CA | 541380 Testing Laboratories and Services |
| Burleson Research Technologies, Inc. | Morrisville, NC | 541380 Testing Laboratories and Services |
| Experimental Pathology Laboratories, Inc. | Sterling, VA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Inotiv, Inc. | West Lafayette, IN | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
About the company
Scitovation, LLC, a Black American-owned, for-profit limited liability company based in Cheshire, Massachusetts, operates as a prime recipient of federal research grants and purchase orders in computational toxicology and chemical safety assessment. The vendor is a subsidiary of Solutem Group, LLC, and does not compete as a federal contract prime or subcontractor — all five of its recent federal awards are grants or direct purchase orders.
Scitovation's capability portfolio centers on in vitro and computational methodologies for toxicity assessment that reduce or eliminate reliance on animal testing. The vendor's current work pipeline includes three Phase I and Phase II Small Business Research Initiative (SBIR) grants from the National Institute of Environmental Health Sciences, each focused on translating laboratory findings into regulatory tools. The first, awarded in July 2023 and completing in February 2025, delivered a Phase I project on mutational profiling using human cells and next-generation sequencing as an in vitro alternative to mammalian cell mutagenicity assays. The second and third, both awarded in July 2023, comprise a Phase II project running through April 2027 on DRIIVE (Developmental and Reproductive In Vitro to In Vivo Extrapolation), a web-based computational application combining in vitro reproductive assays with physiologically-based pharmacokinetic (PBPK) modeling to predict human equivalent developmental toxicity dose levels without animal testing. A September 2026 purchase order from CDC Pittsburgh for $337,915, with performance through September 2029, covers risk assessment work under Executive Order 14398, priced on a firm fixed-price basis.
All five awards are with Department of Health and Human Services entities — the National Institute of Environmental Health Sciences (three awards), CDC Pittsburgh (one award), and the National Institutes of Health (one award). The combined potential value across all awards is $338 thousand, but obligated dollars total $6.3 million, reflecting substantial federal investment in work already performed. One award completes within the next twenty-four months. Scitovation has not recorded sub-award activity or IDV participation in the source data.
SBA capabilities narrative
cell-based research and science, bioinformatics
Quick answers
Is Scitovation, LLC registered in SAM.gov?
Yes. Scitovation, LLC's SAM.gov registration is active through October 6, 2027.
How much has Scitovation, LLC received in federal contracts?
Federal contracts obligated $337,915 to Scitovation, LLC in fiscal years 2023 through 2027.
What is Scitovation, LLC's most recent federal award?
Scitovation, LLC's most recent federal contract award is EO 14398 - risk assessment (75D30126P21609), from CDC Pittsburgh, on September 30, 2026.
On GovTribe
See Scitovation, LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors